Praxis Precision Medicines (PRAX) Earnings Date, Estimates & Call Transcripts $35.80 -2.70 (-7.02%) As of 02:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Praxis Precision Medicines Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 12Before Market OpensEstimatedActual EPS (Feb. 28) -$2.94 Missed By -$0.18 Consensus EPS (Feb. 28) -$2.76 Praxis Precision Medicines announced Q4 2024 earnings on February 28, 2025, reporting an EPS of -$2.94, which missed analysts' consensus estimates of -$2.76 by $0.18. Quarterly revenue was reported to be $7.48 million, above the consensus estimate of $0.36 million. With a trailing EPS of -$10.27, Praxis Precision Medicines' earnings are expected to decrease next year, from ($10.22) to ($12.22) per share. SEC 10-Q/10-K FilingPRAX Upcoming EarningsPraxis Precision Medicines' next earnings date is estimated for Monday, May 12, 2025, based off prior year's reporting schedules. Get Praxis Precision Medicines Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Praxis Precision Medicines and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPRAX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PRAX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Praxis Precision Medicines Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$3.18-$2.14-$2.66Q2 20252-$3.64-$2.29-$2.97Q3 20252-$4.15-$2.42-$3.29Q4 20252-$4.16-$2.60-$3.38FY 20258-$15.13-$9.45-$12.29Q1 20261-$4.39-$4.39-$4.39Q2 20261-$4.82-$4.82-$4.82Q3 20261-$4.89-$4.89-$4.89Q4 20261-$4.90-$4.90-$4.90FY 20264($19.00)($19.00)($19.00) Remove Ads Praxis Precision Medicines Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/12/2025(Estimated)-------2/28/2025Q4 2024-$2.76-$2.94 -$0.18-$2.94$0.36M$7.48M11/6/2024Q3 2024-$2.01-$2.75 -$0.74-$2.75$0.53M$0.30M8/13/2024Q2 2024-$2.38-$1.74+$0.64-$1.74$1.44M$0.36M5/13/2024Q1 2024-$2.01-$2.84 -$0.83-$2.84$2.75M$0.43M3/5/2024Q4 2023-$3.05-$2.97+$0.08-$2.97$0.30M$0.52M11/7/2023Q3 2023-$5.25-$2.70+$2.55-$0.18-$0.47M8/9/2023Q2 2023-$9.90-$7.35+$2.55-$0.49-$0.78M5/11/2023Q1 2023-$11.25-$10.65+$0.60-$0.71-$0.68M Praxis Precision Medicines Earnings - Frequently Asked Questions When is Praxis Precision Medicines's earnings date? Praxis Precision Medicines has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on PRAX's earnings history. Did Praxis Precision Medicines beat their earnings estimates last quarter? In the previous quarter, Praxis Precision Medicines (NASDAQ:PRAX) missed the analysts' consensus estimate of ($2.76) by $0.18 with a reported earnings per share (EPS) of ($2.94). Learn more on analysts' earnings estimate vs. PRAX's actual earnings. How can I view Praxis Precision Medicines's earnings report? Praxis Precision Medicines's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Praxis Precision Medicines generate each year? Praxis Precision Medicines (NASDAQ:PRAX) has a recorded annual revenue of $8.55 million. How much profit does Praxis Precision Medicines generate each year? Praxis Precision Medicines (NASDAQ:PRAX) has a recorded net income of -$123.28 million. PRAX has generated -$10.27 earnings per share over the last four quarters. What is Praxis Precision Medicines's EPS forecast for next year? Praxis Precision Medicines's earnings are expected to decrease from ($10.22) per share to ($12.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies Vericel Earnings Edgewise Therapeutics Earnings Protagonist Therapeutics Earnings Mirum Pharmaceuticals Earnings Arrowhead Pharmaceuticals Earnings Twist Bioscience Earnings Denali Therapeutics Earnings Beam Therapeutics Earnings ImmunityBio Earnings Centessa Pharmaceuticals Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles These 3 Q1 Earnings Winners Will Go HigherAnalysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before Earnings Remove Ads This page (NASDAQ:PRAX) was last updated on 3/10/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWake up and smell the profits!Some people are not ready to change their morning routine... And I’ll be blunt—this lucrative trade strateg...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRAX Stock Alerts